Abstract
Molecular pathways that regulate cell growth and differentiation are now beginning to be understood. This is mainly due to the identification of molecules that orchestrate the cell cycle. Cyclins and the cyclin-dependent kinases (CDKs) are the major players in the control of cell cycle progression. Cyclins do not have enzymatic activity and CDKs are inactive without a partner cyclin. The CDKs regulate the function of multiple proteins involved in DNA replication and mitosis by phosphorylating them at specific regulatory sites, activating some and inhibiting others to coordinate their activities. In this way cyclin/CDK complexes coordinate an ordered passage from a cell cycle phase to the next one. Multiple levels of regulation of cyclin/CDK complexes are present in “cell machinery” to obtain a tight control of cell cycle progression. In this chapter we will address these items.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pucci B, Kasten M, Giordano A (2000) Cell cycle and apoptosis. Neoplasia 2(4):291–299
Harper JV, Brooks G (2005) The mammalian cell cycle: an overview. Methods Mol Biol 296:113–153
Collado M, Blasco MA, Serrano M (2007) Cellular senescence in cancer and aging. Cell 130(2):223–233
Crews DE (2007) Senescence, aging, and disease. J Physiol Anthropol 26(3):365–372
Donjerkovic D, Scott DW (2000) Regulation of the G1 phase of the mammalian cell cycle. Cell Res 10(1):1–16
Chiariello M, Gomez E, Gutkind JS (2000) Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase. Biochem J 349 Pt 3:869–876
Lolli G, Johnson LN (2005) CAK-cyclin-dependent activating kinase: a key kinase in cell cycle control and a target for drugs? Cell Cycle 4(4):572–577
Hu X et al (2002) Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest. J Biol Chem 277(19):16528–16537
Perkins ND (2002) Not just a CDK inhibitor: regulation of transcription by p21(WAF1/CIP1/SDI1). Cell Cycle 1(1):39–41
Slingerland J, Pagano M (2000) Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 183(1):10–17
Yang W et al (2007) Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1. J Biol Chem 282(6):3799–3808
Minshull J (1993) Cyclin synthesis: who needs it? Bioessays 15(3):149–155
Hershko A (1999) Mechanisms and regulation of the degradation of cyclin B. Philos Trans R Soc Lond B Biol Sci 354(1389):1571–1575; discussion 1575–1576
Alao JP (2007) The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 6:24
De Clercq A, Inze D (2006) Cyclin-dependent kinase inhibitors in yeast, animals, and plants: a functional comparison. Crit Rev Biochem Mol Biol 41(5):293–313
Fischer PM, Endicott J, Meijer L (2003), Cyclin-dependent kinase inhibitors. Prog Cell Cycle Res 5:235–248
Santamaria D, Ortega S (2006) Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci 11:1164–1188
Sridhar J, Akula N, Pattabiraman N (2006) Selectivity and potency of cyclin-dependent kinase inhibitors. Aaps J 8(1):E204–221
Harbour JW et al (1999) Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98(6):859–869
Kasten MM, Giordano A (1998) pRb and the cdks in apoptosis and the cell cycle. Cell Death Differ 5(2):132–140
Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79(4):551–555
Stiegler P, Kasten M, Giordano A (1998) The RB family of cell cycle regulatory factors. J Cell Biochem Suppl 30–31:30–36
Watanabe Y et al (1999) pRb phosphorylation is regulated differentially by cyclin-dependent kinase (Cdk) 2 and Cdk4 in retinoic acid-induced neuronal differentiation of P19 cells. Brain Res 842(2):342–350
Ortega S, Malumbres M, Barbacid M (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602(1):73–87
Motokura T, Arnold A (1993) Cyclin D and oncogenesis. Curr Opin Genet Dev 3(1):5–10
Bracken AP et al (2004) E2F target genes: unraveling the biology. Trends Biochem Sci 29(8):409–417
Lavia P, Jansen-Durr P (1999) E2F target genes and cell-cycle checkpoint control. Bioessays 21(3):221–230
Lundberg AS, Weinberg RA (1999) Control of the cell cycle and apoptosis. Eur J Cancer 35(14):1886–1894
Blagosklonny MV, Pardee AB (2002) The restriction point of the cell cycle. Cell Cycle 1(2):103–110
DelSal G, Loda M, Pagano M (1996) Cell cycle and cancer: critical events at the G1 restriction point. Crit Rev Oncog 7(1–2):127–142
Claudio PP et al (1996) Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res 56(9):2003–2008
Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81(3):323–330
Harper JW et al (1995) Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6(4):387–400
Li Y et al (1994) Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9(8):2261–2268
Pavletich NP (1999) Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol 287(5):821–828
Kellogg DR (2003) Wee1-dependent mechanisms required for coordination of cell growth and cell division. J Cell Sci 116(Pt 24):4883–4890
Perry JA, Kornbluth S (2007) Cdc25 and Wee1: analogous opposites? Cell Div 2:12
Rudolph J (2007) Cdc25 phosphatases: structure, specificity, and mechanism. Biochemistry 46(12):3595–3604
Wells NJ et al (1999) The C-terminal domain of the Cdc2 inhibitory kinase Myt1 interacts with Cdc2 complexes and is required for inhibition of G(2)/M progression. J Cell Sci 112(Pt 19):3361–3371
Strausfeld UP et al (1996) Both cyclin A and cyclin E have S-phase promoting (SPF) activity in Xenopus egg extracts. J Cell Sci 109(Pt 6):1555–1563
Woo RA, Poon RY (2003) Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle 2(4):316–324
Hayashi S, Yamaguchi M (1999) Kinase-independent activity of Cdc2/cyclin A prevents the S phase in the Drosophila cell cycle. Genes Cells 4(2):111–122
Jacobs HW, Keidel E, Lehner CF (2001) A complex degradation signal in Cyclin A required for G1 arrest, and a C-terminal region for mitosis. Embo J 20(10):2376–2386
Girard F et al (1991) Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67(6):1169–1179
Kishimoto T, Okumura E (1997) In vivo regulation of the entry into M-phase: initial activation and nuclear translocation of cyclin B/Cdc2. Prog Cell Cycle Res 3:241–249
Nurse P (1994) Ordering S phase and M phase in the cell cycle. Cell 79(4):547–550
Tokumoto T et al (1997) Initiation of cyclin B degradation by the 26S proteasome upon egg activation. J Cell Biol 138(6):1313–1322
Tschop K et al (2006) Human cyclin B3. mRNA expression during the cell cycle and identification of three novel nonclassical nuclear localization signals. FEBS J 273(8):1681–1695
Bellanger S, de Gramont A, Sobczak-Thepot J (2007) Cyclin B2 suppresses mitotic failure and DNA re-replication in human somatic cells knocked down for both cyclins B1 and B2. Oncogene 26(51):7175–7184
Chesnel F et al (2006) Cyclin B dissociation from CDK1 precedes its degradation upon MPF inactivation in mitotic extracts of Xenopus laevis embryos. Cell Cycle 5(15):1687–1698
Gong D et al (2007) Cyclin A2 regulates nuclear-envelope breakdown and the nuclear accumulation of cyclin B1. Curr Biol 17(1):85–91
Walsh S, Margolis SS, Kornbluth S (2003) Phosphorylation of the cyclin b1 cytoplasmic retention sequence by mitogen-activated protein kinase and Plx. Mol Cancer Res 1(4):280–289
Booher RN, Holman PS, Fattaey A (1997) Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J Biol Chem 272(35):22300–22306
Berry LD, Gould KL (1996) Regulation of Cdc2 activity by phosphorylation at T14/Y15. Prog Cell Cycle Res 2:99–105
Hoffmann I, Karsenti E (1994) The role of cdc25 in checkpoints and feedback controls in the eukaryotic cell cycle. J Cell Sci Suppl 18:75–79
Jessus C, Ozon R (1995) Function and regulation of cdc25 protein phosphate through mitosis and meiosis. Prog Cell Cycle Res 1:215–228
Mueller PR et al (1995) Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 270(5233):86–90
Baker DJ et al (2007) Mitotic regulation of the anaphase-promoting complex. Cell Mol Life Sci 64(5):589–600
Fang G, Yu H, Kirschner MW (1999) Control of mitotic transitions by the anaphase-promoting complex. Philos Trans R Soc Lond B Biol Sci 354(1389):1583–1590
Page AM, Hieter P (1999) The anaphase-promoting complex: new subunits and regulators. Annu Rev Biochem 68:583–609
Pietenpol JA, Stewart ZA (2002) Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology 181–182:475–481
van Vugt MA, Bras A, Medema RH (2005) Restarting the cell cycle when the checkpoint comes to a halt. Cancer Res 65(16):7037–7040
Peeper DS, van der Eb AJ, Zantema A (1994) The G1/S cell-cycle checkpoint in eukaryotic cells. Biochim Biophys Acta 1198(2–3):215–230
Little JB (1968) Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature 218(5146):1064–1065
Gu Y, Rosenblatt J, Morgan DO (1992) Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J 11(11):3995–4005
Sebastian B, Kakizuka A, Hunter T (1993) Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci U S A 90(8):3521–3524
Terada Y et al (1995) Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376(6538):358–362
Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351(6326):453–456
Kastan MB et al (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51(23 Pt 1):6304–6311
Maltzman W, Czyzyk L (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4(9):1689–1694
Campbell C et al (1993) Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation. Cancer Res 53(12):2697–2679
Di Leonardo A et al (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8(21):2540–2551
Nelson WG, Kastan MB (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol Cell Biol 14(3):1815–1823
Xiong Y et al (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366(6456):701–704
Harper JW et al (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75(4):805–816
Deng C et al (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82(4):675–684
Gottifredi V, Prives C (2005) The S phase checkpoint: when the crowd meets at the fork. Semin Cell Dev Biol 16(3):355–368
Painter RB, Young BR (1976) Formation of nascent DNA molecules during inhibition of replicon initiation in mammalian cells. Biochim Biophys Acta 418(2):146–153
Painter RB, Young BR (1980) Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci U S A 77(12):7315–7317
Beamish H et al (1996) Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J Biol Chem 271(34):20486–20493
O’Connell MJ, Walworth NC, Carr AM (2000) The G2-phase DNA-damage checkpoint. Trends Cell Biol 10(7):296–303
Lock RB, Ross WE (1990) Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. Cancer Res 50(12):3761–3766
Lock RB, Ross WE (1990) Possible role for p34cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells. Cancer Res 50(12):3767–3771
Paules RS et al (1995) Defective G2 checkpoint function in cells from individuals with familial cancer syndromes. Cancer Res 55(8):1763–1773
Herzinger T et al (1995) Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase. Oncogene 11(10):2151–2156
Gallant P, Nigg EA (1992) Cyclin B2 undergoes cell cycle-dependent nuclear translocation and, when expressed as a non-destructible mutant, causes mitotic arrest in HeLa cells. J Cell Biol 117(1):213–224
Pines J, Hunter T (1989) Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58(5):833–846
Rudner AD, Murray AW (1996) The spindle assembly checkpoint. Curr Opin Cell Biol 8(6):773–780
Murray AW (1995) The genetics of cell cycle checkpoints. Curr Opin Genet Dev 5(1):5–11
Lenart P, Peters JM (2006) Checkpoint activation: don't get mad too much. Curr Biol 16(11):R412–414
Vanoosthuyse V et al (2004) Kinetochore targeting of fission yeast Mad and Bub proteins is essential for spindle checkpoint function but not for all chromosome segregation roles of Bub1p. Mol Cell Biol 24(22):9786–9801
Pinsky BA, Biggins S (2005) The spindle checkpoint: tension versus attachment. Trends Cell Biol 15(9):486–493
Lens SM, Medema RH (2003) The survivin/Aurora B complex: its role in coordinating tension and attachment. Cell Cycle 2(6):507–510
Goulding SE, Earnshaw WC (2005) Shugoshin: a centromeric guardian senses tension. Bioessays 27(6):588–591
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Giordano, A., Galderisi, U. (2010). Short Introduction to the Cell Cycle. In: Giordano, A., Galderisi, U. (eds) Cell Cycle Regulation and Differentiation in Cardiovascular and Neural Systems. Springer, New York, NY. https://doi.org/10.1007/978-1-60327-153-0_1
Download citation
DOI: https://doi.org/10.1007/978-1-60327-153-0_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-60327-152-3
Online ISBN: 978-1-60327-153-0
eBook Packages: MedicineMedicine (R0)